Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

ECB. 2022; 11(11): 64-72


POTENTIAL CARDIOVASCULAR SIDE EFFECTS OF TRENBOLONE ACETATE STEROID STACKING IN YOUNG RECREATIONAL BODYBUILDERS COMPARED WITH ANOTHER POTENTIAL CARDIOVASCULAR SIDE EFFECTS OF ANABOLIC STEROIDS AND WHAT IS THOROUGHLY HIDING BEHIND TRENBOLONE ACETATE ROID RAGE MYTH? (PILOT STUDY)

Sid Solakovic, Nina Solakovic, Amina Godinjak, Mensur Vrcic, Ratko Pavlović, Iryna Skrypchenko, Olena Dorofieieva, Kseniya Yarymbash.




Abstract

Aim: Health price of victorious and synthetic rapid muscle gain is never cheap. Many young recreational bodybuilders deceived by muscle dysmorphia search a shortcut to rapid muscle definition, muscle gain muscle hardness, tempted dally to involve steroids in their trainings cycle such as Trenbolone Acetate, one off the most effective metabolic violent steroids with very strong anabolic and psychopathologic potential (Roid Rage) considerably more stronger than testosterone promoting rapid muscle mass with relative muscle hardness and definition.
Subjects and methods: This study was conducted from beginning of June, 2019 till end of June, 2021 at the Clinic of Vascular Surgery, Clinical Center University of Sarajevo and included 72 subjects age 18-35 (37 subjects who have Trenbolone Stack in their anabolic steroids cycles and impellers group consisting of 35 subjects who have Trenbolone Stack in their anabolic steroids cycles ) Potential Cardiovascular Side Effects are investigated For the testing of statistical significance of differences between the examined groups non-parametar and parameter tests were used. The difference at a level of p

Key words: Anabolic Steroids, Cardiovascular Side Effects, Trenbolone acetate, Stacking effect






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.